retatrutide mechanism glp-1 gip glucagon triple agonist Retatrutide—A Game Changer in Obesity Pharmacotherapy How Does Retatrutide Work? Doctor
Description
A Systematic Review and Meta-Analysis of Studies Assessing Body Weight Outcomes after Interventions with Increased Dietary Protein
Kapitza C, Nosek L, Jensen L, et al
Overuse in Non-Clinical Cases Some individuals are using GLP-1s without meeting current medical guidelines, creating potential for misuse or overuse and perpetuating an unrealistic standard of thinness
Retatrutide is a once weekly injectable medication developed by Eli Lilly
Tirzepatide has been approved for weight management and has demonstrated significant weight loss outcomes in clinical trials
